Log In
BCIQ
Print this Print this
 

NKTR-218

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionPolythylene glycolated (PEG) prodrug of an indoleamine 2,3-dioxygenase (INDO) (IDO) inhibitor conjugated by a hydrolyzable linker
Molecular Target Indoleamine 2,3-dioxygenase (INDO) (IDO)
Mechanism of ActionIndoleamine 2,3-dioxygenase (INDO) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today